User profiles for Marc Lambert
 | Marc LambertMD PhD, Medicine Faculty, LILLE University Verified email at chru-lille.fr Cited by 11413 |
[HTML][HTML] Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
…, X Kyndt, F Lifermann, T Papo, M Lambert… - … England Journal of …, 2008 - Mass Medical Soc
Background Current standard therapy for Wegener's granulomatosis and microscopic
polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed by a …
polyangiitis combines corticosteroids and cyclophosphamide to induce remission, followed by a …
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
…, L Fourcade, JP Mouret, M Lambert… - European heart …, 2017 - academic.oup.com
Aims Newer P2Y12 blockers (prasugrel and ticagrelor) demonstrated significant ischaemic
benefit over clopidogrel after acute coronary syndrome (ACS). However, both drugs are …
benefit over clopidogrel after acute coronary syndrome (ACS). However, both drugs are …
Echocardiography predicts embolic events in infective endocarditis
…, J Gouvernet, P Ambrosi, M Lambert… - Journal of the American …, 2001 - jacc.org
OBJECTIVES The aim of our study was to assess the value of transesophageal echocardiography
(TEE) in predicting embolic events (EEs) in a large group of patients with definite …
(TEE) in predicting embolic events (EEs) in a large group of patients with definite …
Survival and prognostic factors in systemic sclerosis–associated pulmonary hypertension: a systematic review and meta‐analysis
Objective Pulmonary hypertension (PH) is a frequent and life‐limiting complication of systemic
sclerosis (SSc). However, data on survival rates and their evolution over time, as well as …
sclerosis (SSc). However, data on survival rates and their evolution over time, as well as …
Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non–ST-segment elevation acute coronary syndrome …
…, L Nait-Saidi, J Carvajal, A Lehmann, M Lambert… - Journal of the American …, 2006 - jacc.org
Objectives : We analyzed the benefit of a 600-mg clopidogrel loading dose on platelet
reactivity and clinical outcomes after stenting for non–ST-segment elevation acute coronary …
reactivity and clinical outcomes after stenting for non–ST-segment elevation acute coronary …
Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience
Background— With recent advances in endovascular treatment, percutaneous endoluminal
angioplasty has become particularly attractive for arterial lesions of Takayasu arteritis. …
angioplasty has become particularly attractive for arterial lesions of Takayasu arteritis. …
Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.
OBJECTIVE: To describe the natural history of ischemic digital ulcers (DU) in systemic sclerosis
(SSc). METHODS: This single-center, retrospective, longitudinal study identified patients …
(SSc). METHODS: This single-center, retrospective, longitudinal study identified patients …
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
…, R Forastiero, P De Groot, G Lakos, M Lambert… - Autoimmunity …, 2014 - Elsevier
Current classification criteria for definite Antiphospholipid Syndrome (APS) require the use
of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in …
of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in …
Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome
…, L Camoin-Jau, N Saut, D Faille, M Lambert… - The American journal of …, 2008 - Elsevier
Genetic polymorphisms of cytochrome P450 (CYP) isoforms may promote variability in platelet
response to clopidogrel. This study was conducted to analyze, in 603 patients with non–…
response to clopidogrel. This study was conducted to analyze, in 603 patients with non–…
Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases
The formation of advanced glycation end products (AGEs) is a result of the non-enzymatic
reaction between sugars and free amino groups of proteins. AGEs, through interacting with …
reaction between sugars and free amino groups of proteins. AGEs, through interacting with …